Ascendis Pharma A/S
(ASND)
undefined
undefined%
At close: undefined
129.87
-0.29%
After-hours Dec 13, 2024, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
Cash & Equivalents | 392.16M | 444.77M | 446.27M | 584.52M | 598.11M | 277.86M | 195.35M | 180.33M | 119.65M | 50.17M | 19.43M | 14.54M | 15.68M |
Short-Term Investments | 7.28M | 290.69M | 235.80M | 134.28M | - | - | - | - | - | - | - | - | - |
Long-Term Investments | 5.69M | 30.42M | 145.91M | 124.46M | 15.54M | 17.08M | - | - | - | - | - | - | - |
Other Long-Term Assets | 2.13M | 1.92M | 1.81M | 1.38M | 1.46M | 1.16M | 293.00K | 268.00K | 270.00K | 140.00K | 33.00K | 31.00K | 32.00K |
Receivables | 55.77M | 11.91M | 2.20M | 387.00K | 804.00K | 2.63M | 2.38M | 287.00K | 1.06M | 1.29M | 1.71M | 6.07M | 2.02M |
Inventory | 208.93M | 130.67M | 75.41M | 1.00 | -3 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | - | - | - |
Other Current Assets | 38.58M | 45.43M | 46.22M | 13.99M | 7.65M | 12.41M | 6.91M | 1.96M | 3.82M | 620.00K | 64.00K | 90.00K | 271.00K |
Total Current Assets | 702.72M | 923.47M | 805.89M | 740.13M | 611.17M | 292.91M | 204.63M | 183.96M | 125.65M | 53.16M | 21.20M | 20.70M | 17.97M |
Property-Plant & Equipment | 110.63M | 129.09M | 126.05M | 108.11M | 45.07M | 4.33M | 2.56M | 2.35M | 2.35M | 1.87M | 1.97M | 1.18M | 1.32M |
Goodwill & Intangibles | 4.42M | 4.83M | 5.27M | 5.72M | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M |
Total Long-Term Assets | 122.87M | 166.27M | 279.04M | 239.66M | 65.56M | 26.06M | 6.34M | 6.11M | 6.12M | 5.51M | 5.50M | 4.71M | 4.84M |
Total Assets | 825.59M | 1.09B | 1.08B | 979.79M | 676.73M | 318.97M | 210.98M | 190.07M | 131.77M | 58.67M | 26.70M | 25.41M | 22.82M |
Account Payables | 94.57M | 101.03M | 59.42M | 21.90M | 27.77M | 19.74M | 17.43M | 13.08M | 8.37M | 4.96M | 2.52M | 2.53M | 2.52M |
Deferred Revenue | - | - | 2.60M | 363.00K | 858.00K | 6.90M | - | 94.00K | 3.07M | 7.91M | 17.47M | 21.08M | 19.67M |
Short-Term Debt | 25.40M | 25.42M | 13.99M | 6.86M | 5.90M | - | - | - | - | - | - | 212.00K | 187.00K |
Other Current Liabilities | 75.08M | 39.33M | 26.75M | 23.75M | 14.21M | 19.17M | 6.33M | 94.00K | - | - | 17.47M | - | - |
Total Current Liabilities | 197.34M | 171.27M | 100.36M | 52.80M | 47.99M | 38.92M | 23.77M | 13.46M | 11.45M | 12.86M | 20.40M | 23.85M | 22.37M |
Long-Term Debt | 618.87M | 482.96M | 97.97M | 85.12M | 30.72M | - | - | - | - | - | - | - | 213.00K |
Other Long-Term Liabilities | 155.07M | 172.16M | 2.96M | 3.16M | 908.00K | - | - | - | - | - | - | - | - |
Total Long-Term Liabilities | 773.94M | 655.12M | 100.93M | 88.28M | 31.63M | 26.64M | 23.77M | 13.17M | 11.45M | 12.86M | 19.99M | 23.83M | 213.00K |
Total Liabilities | 971.28M | 826.39M | 201.29M | 141.08M | 79.62M | 38.92M | 23.77M | 13.46M | 11.45M | 12.86M | 20.40M | 23.85M | 22.59M |
Total Debt | 644.26M | 508.38M | 104.96M | 91.97M | 36.62M | - | - | - | - | - | - | 212.00K | 400.00K |
Common Stock | 7.75M | 7.67M | 7.65M | 7.22M | 6.44M | 5.66M | 4.97M | 4.35M | 3.37M | 2.27M | 1.45M | 1.45M | 1.45M |
Retained Earnings | -2.28B | -1.86B | -1.41B | -1.03B | -611.32M | -393.31M | -263.21M | 159.25M | 111.28M | 39.56M | 2.13M | -1.95M | -3.19M |
Comprehensive Income | -153.45M | 255.67M | 875.99M | 831.49M | 590.67M | 274.39M | 182.24M | 13.01M | 5.68M | 3.98M | 2.72M | 2.05M | 1.98M |
Shareholders Equity | -145.70M | 263.35M | 883.63M | 838.71M | 597.11M | 280.05M | 187.21M | 176.61M | 120.33M | 45.81M | 6.30M | 1.56M | 233.00K |
Total Investments | 12.96M | 321.11M | 381.70M | 258.73M | 15.54M | 17.08M | - | - | - | - | - | - | - |